Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsTargeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical ApproachesNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityAntitumor Responses of Invariant Natural Killer T CellsCritical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressImmunological battlefield in gastric cancer and role of immunotherapiesGlycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionCytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.Genetics, genomics, and evolutionary biology of NKG2D ligands.NKG2D Receptor and Its Ligands in Host DefenseImmunity, inflammation, and cancer: an eternal fight between good and evil.Immunosurveillance and immunotherapy of tumors by innate immune cells.Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours.Expression and prognostic significance of unique ULBPs in pancreatic cancerSelective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System.The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activityCBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cellsAlternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.Antigen Loss Variants: Catching Hold of Escaping Foes.VEGFR2-targeted fusion antibody improved NK cell-mediated immunosurveillance against K562 cells.NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitorsRegulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis.A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.Antibody targeting soluble NKG2D ligand sMIC refuels and invigorates the endogenous immune system to fight cancer.Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.Distinct mechanisms of tumor resistance to NK killing: of mice and men.Shed NKG2D ligand boosts NK cell immunityThe dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermiaThe immune system in cancer metastasis: friend or foe?TriKEs and BiKEs join CARs on the cancer immunotherapy highway.Endothelial cells express NKG2D ligands and desensitize anti-tumor NK responses.Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases.Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors.An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells.
P2860
Q26751011-FF8F868C-B7D6-40FB-9480-ABB81EB05E4FQ26752518-61C2B60B-CD22-4DA4-89B4-37E87E930F75Q26772347-9CF47BB6-E5BB-4F5D-B207-10D135A2FBFDQ26773135-60D8F75D-CBBE-4865-906E-ACB4FE346287Q26778648-419CB3AA-0401-4EFC-A468-E5B1C80DAEC8Q26781260-F82AABDA-60FF-4BF9-9CA5-869DC5F2758AQ28071836-2693520A-E2A2-46A7-8012-DDEC70BC46C7Q28076151-FC825C0A-99C6-4B85-BF63-C52B765EC5D7Q30648415-ED6211CC-AF87-463A-92BC-BAE61CD11247Q34489980-D0934092-923C-4D39-9537-1410886C64B4Q35687826-3DB8967A-BC80-4EFB-871F-63082421A3CAQ36106053-A52B2DB8-2EF6-4A50-A5AE-11B2173518C7Q36471212-8946052E-CFD0-48AA-9452-9D7E8F4F5AFEQ37137278-C0B830FF-5E74-4EE0-B71E-4A66DE7EB84FQ37229770-3E2A25F7-07CB-4152-B681-4342AE57342EQ37281838-5D114D3F-B084-4849-9EA7-FBFE61D64C44Q37598020-13345D94-0655-41AF-B15F-7A8C7B5DFBBAQ37622429-5C907AE2-7D0B-4C3F-8BAB-C0E71048B431Q37644845-353658BE-6C54-4A6F-9817-4E39CE2A2311Q37654516-E43CC597-5EBE-40AE-911A-33DF91624403Q38762336-9F2F9E65-B97B-4E88-A4DF-CD46764C1ADEQ38794091-182FF164-8932-48BD-A616-A328AF0E48D6Q38860610-2D6EAC14-8449-42DF-9314-9F6824CA32BBQ38958563-DD97C12E-8A6A-4235-A309-3A5EB411DA54Q39175440-75856A51-4033-4891-88A0-0E44EEC93788Q39787455-62C5987B-6244-4334-BB96-723A8A167BC8Q39798606-35D9656E-5002-41D7-9CAE-C9C87FA8EE7AQ40098295-ADB1C54F-A99C-4A8C-A7D3-B7130162C756Q40257100-32403C9C-D5A7-4910-AD0A-2A3C28E2A0E0Q40436097-4F5D847F-45FB-4B96-B983-81E556D62F27Q41067927-7ED31DBF-5BC1-404F-8439-40DF154F6E3CQ41097352-3423E357-ACA4-442A-AA0F-300D4753EBD5Q42148086-39B59572-6B51-4E1F-82DD-C7771188985EQ42427640-BB53ACF6-5A28-4411-8EE9-855D067CC7CEQ42656251-88D74B4C-C741-4AAB-9AA7-B42862CB593DQ42801713-5B1A74F0-8542-4EE1-B5E1-8E62A47A3E0BQ46018291-B0C6E3F2-0647-470A-85B9-89A1DB3B0B92Q46884989-A7AE634E-3A41-483A-B7D1-A5290EFEC466Q47114951-D4AA0A76-B1CD-4014-B766-41C28BD34D36Q49884881-71AAD947-93F6-4C35-A172-94442E3260D7
P2860
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.
@en
type
label
Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.
@en
prefLabel
Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.
@en
P2093
P2860
P50
P356
P1433
P1476
Antitumor immunity. A shed NKG ...... ctivation and tumor rejection.
@en
P2093
Alexandre Iannello
Jianfeng Xu
Stephanie Lau
Weiwen Deng
P2860
P304
P356
10.1126/SCIENCE.1258867
P407
P577
2015-03-05T00:00:00Z